Chronic Fatigue Syndrome Clinical Trial
Official title:
Effectiveness of Acupressure Treatment in Pain Management and Fatigue Relief for Gulf War Veterans
This study will provide symptomatic veterans with acupressure treatment and determine its
effectiveness in fatigue relief and pain management for Gulf War Illness (GWI). Investigators
plan to recruit patients reporting symptoms of GWI through the Department of Veterans Affairs
(VA), and randomize them into acupressure group (to receive acupressure treatment) and
control group (to receive Reiki treatment). The acupressure treatment, twice per week for 6
weeks, will be offered by a licensed acupressure practitioner. Evaluations will be made
before and after treatment (at 6 weeks). Clinical outcomes will be compared between groups
(acupressure group vs. control group) and between different timepoints (before treatment vs.
after treatment) within the same group.
The results of this study may provide useful information to develop more effective treatment
for veterans with GWI disease. Since acupressure treatment is of Asian origin and has shown
excellent promise within its Eastern traditions, if successful, this study has the potential
to produce a paradigm shift in clinical practice to more effectively relieve the symptoms of
veterans with GWI disease. Meanwhile, as a non-invasive therapeutic massage, acupressure may
lend to better patient acceptance and ultimately, greater clinical accessibility.
Hypotheses
1. Acupressure besides routine clinical care will produce a more complete fatigue relief
and pain alleviation in veterans with GWI versus routine clinical care plus reiki
treatment.
2. EEG measures will exhibit a positive change when fatigue is relieved and pain is
alleviated for symptomatic veterans after effective treatment.
Symptomatic veterans will receive standardized acupressure treatment, first with one-thumb
pressing applied to the head at acupoints of GV-20 (Bai Hui), EX-HN-3 (Yin Tang), Du-24 (Shen
Ting), ST-8 (Tou Wei), EX-HN-5 (Tai Yang). B-2 (Zan Zhu), M-HN-6 (Yu Yao), and SJ-23 (Si Zhu
Kong) for ~5 s on each acupoint until the subject gets the sense of soreness and numbness,
and the procedure will be repeated three times. The frequency of one-thumb pressing is 120±10
times per minute and the force is 10±2 Newtons. Kneading massage will be applied around eyes
and forehead, and face will be swabbed by palm for ~ 5 min. Manipulation of these acupoints
is aimed at helping to calm and ease the subject, lighten headache and migraine, relieve
fatigue, and alleviate insomnia. Finally, LI- 4 (He Gu), LI-11 (Qu Chi), HT-7(Shen Men),
ST-32 (Fu Tu), SP-10 (Xue Hai), ST-36 (Zu San Li), and KI-3 (Tai Xi) acupoints will be
one-thumb pressed for 10 min. Manipulations on these acupoints and meridians located on the
limbs is to relax muscles, alleviate muscle and joint pain, and improve mobility. This
protocol is based on our consultant's previous acupressure research and clinical practice,
our pilot case study for CFS patient, and the basic rationale in traditional Chinese
acupressure medicine (Yan, 2003; Cao, 2006).
A matter of great concern in investigating oriental alternative and complementary
interventions is standardizability and repeatability of experiments. In this proposed study
the process of identifying the location of acupoints and underlying meridians for each
subject will be carried out using Western anatomy and the World Health Organization's
Standard Acupuncture Point Locations (Lim, 2009). The level of manipulation (force and
frequency of pressing and kneading) will be monitored by the TN-II manipulation radiometer
(Shangxin Medical Science & Technology Co. Ltd, Shanghai, China), which has been successfully
used to normalize acupressure manipulation in previous research (Ma et al., 2006). In this
manner, the whole treatment design would be standardized as much as possible and could be
repeated in the future by our own and other groups.
Reiki: Veterans in the control group will receive reiki treatment with the same dosage (40
min/session, 12 sessions in 6 wks). The practitioner will place the hands on the recipient in
various positions covering head, the back of the torso, and the 4 limbs with fixed set of 12
hand positions. These covered areas will then be tapped and stroked, and practitioner will
focus his/her gaze on these areas for 2-3 min, through which the healing energy is
transferred to the subjects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05454683 -
Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT01686074 -
Motor Control in Chronic Fatigue Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT01651754 -
Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT00540254 -
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00071162 -
Genetics of Fibromyalgia
|
N/A | |
Withdrawn |
NCT04870476 -
Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily Distress Syndrome
|
N/A | |
Completed |
NCT05730660 -
Quercetin Phytosome® Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT04542161 -
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Phase 2 | |
Recruiting |
NCT03807973 -
Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.
|
Phase 1 | |
Recruiting |
NCT05719493 -
Effectiveness and Health Benefits of a Nutritional, Chronobiological and Physical Exercise Intervention in Fibromyalgia and Chronic Fatigue Syndrome (SYNCHRONIZE +)
|
N/A | |
Recruiting |
NCT05967052 -
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
|
Phase 2 | |
Terminated |
NCT01730495 -
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01650636 -
Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process
|
N/A | |
Completed |
NCT01156909 -
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01046370 -
A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia
|
N/A | |
Completed |
NCT00100412 -
Hyporeactivity and Gulf War Illness
|
N/A | |
Recruiting |
NCT06128967 -
A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
|
Phase 3 | |
Completed |
NCT02669212 -
Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
|
N/A | |
Not yet recruiting |
NCT06011135 -
Exploring Worry in CFS/ME
|
||
Completed |
NCT03844412 -
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
|
Phase 2 |